December 13, 2024 - 21:27

As Congress approaches a critical deadline, Senator Tammy Baldwin is focused on resolving pressing issues before the end of the current session. With only until December 20 to secure a funding agreement, the urgency has intensified. The potential for a government shutdown looms large if lawmakers fail to reach a consensus on budgetary matters.
Baldwin has emphasized the importance of bipartisan cooperation in tackling the challenges ahead. She is particularly concerned about the impacts of funding lapses on essential services and programs that millions of Americans rely on. The senator has been actively engaging with her colleagues to foster dialogue and find common ground on key appropriations.
As the clock ticks down, Baldwin remains hopeful that Congress can overcome partisan divides and finalize a deal that will ensure the government's continued operation. The coming weeks will be crucial in determining whether lawmakers can effectively address this "unfinished business" before the deadline arrives.
May 16, 2026 - 00:10
Blake's Snow Shack owned by man with Down syndrome in Texas turns 10In the small North Texas town of Sanger, a beloved local business is marking a sweet anniversary. Blake`s Snow Shack, a shaved ice stand owned and operated by a man with Down syndrome, is turning...
May 15, 2026 - 04:31
SBA Launches Small Business Pitch Competition » CBIAThe U.S. Small Business Administration has announced a new pitch competition aimed at companies that show strong innovation and have a track record of using SBA-backed financing tools. The contest...
May 14, 2026 - 01:02
INOVIO Reports First Quarter 2026 Financial Results and Recent Business HighlightsINOVIO has released its financial results for the first quarter of 2026, alongside a summary of recent business developments. The company`s primary focus remains on the regulatory path for its lead...
May 13, 2026 - 04:15
Curis Provides First Quarter 2026 Business UpdateCuris, Inc., a biotechnology company advancing the development of its lead drug candidate emavusertib, provided a business update for the first quarter of 2026. The company is focused on...